Spelling suggestions: "subject:"[een] SUBSTANCE ABUSE"" "subject:"[enn] SUBSTANCE ABUSE""
381 |
Applying the Relapse Model to Harm Reduction: The Development and Evaluation of the Harm Reduction Self-Efficacy QuestionnairePhillips, Kristina T. 07 November 2005 (has links)
No description available.
|
382 |
Using the Health Belief Model to Predict Injecting Drug Users' Use of Harm ReductionBonar, Erin Elizabeth 20 June 2011 (has links)
No description available.
|
383 |
An exploratory study of families of the substance abusing mentally ill: Burden, stigma and social supportSilver, Thelma January 1995 (has links)
No description available.
|
384 |
Psychopathology and substance abuse among adolescents with psychiatric disordersSong, Li-Yu January 1993 (has links)
No description available.
|
385 |
Parental Influences on Hispanic Adolescent Heroin UseCapece, Alexandra E. January 2013 (has links)
No description available.
|
386 |
Brief Motivational Intervention for Substance Abuse Treatment Retention in Homeless MenIckes, Kelly A. January 2009 (has links)
No description available.
|
387 |
Strength in the Midst of Pain: Relationship Power, Victimization, and HIV Risk Behaviors among Substance Abusing African American WomenAhuama-Jonas, Chizara U. 30 May 2014 (has links)
No description available.
|
388 |
The Relationship of Urgency to Impulsive Decision-Making During Heightened Affective States in Problem DrinkersMorgan, Brittni V. 01 October 2018 (has links)
No description available.
|
389 |
Vocational Rehabilitation for Persons with Dual Diagnoses: Specific Service Patterns that Enhance Earnings at the Time of Case ClosurePaugh, Charles R. 27 February 2003 (has links)
No description available.
|
390 |
Cocaine and HIV-1 Tat Alter Astrocyte Energetics and Essential Neuronal Substrate SupplyCotto, Bianca January 2019 (has links)
While peripheral viral loads can be largely controlled by combination antiretroviral therapy, a significant number of people with HIV (PWH) suffer from HIV-associated neurocognitive disorders (HAND). Cocaine use is a major risk factor for becoming HIV infected, and data have shown that HIV+ cocaine user individuals have worse neurocognitive impairments than those observed from either disease alone. The HIV protein Tat and cocaine synergize to cause damage to neurons in the brain, but astrocytes in the central nervous system (CNS) are an understudied population in these individuals. Importantly, astrocytes support neurons metabolically by supplying key metabolites such as lactate and cholesterol to meet the large energy demands of neurons. Astrocyte-derived lactate is taken up by neurons to serve as a key substrate for ATP production. Additionally, the brain requires an intricate balance of cholesterol to support synaptodendritic communications. Disruption of cholesterol supply and energy deficits have been implicated in brain aging and many neurodegenerative diseases including Alzheimer’s disease. There have been reports of altered brain metabolite profiles in PWH indicative of changes in energy homeostasis. We hypothesized that cocaine and Tat work together to disrupt astrocyte energy metabolism. These changes in energy demand compromise the astrocyte’s ability to support neurons leading to neuronal dysfunction and worsening HAND. Our data show that exposure of astrocytes to cocaine and Tat significantly enhances aerobic glycolysis and decreases lactate production. Our findings also demonstrate that cocaine and Tat decrease astrocyte-derived cholesterol, pointing to a deficiency in cholesterol supply and efflux for use by neurons. These findings are supported in the Tat transgenic mouse model of chronic cocaine use. Taken together, these data uncover novel alterations in the bioenergetics pathway in astrocytes exposed to cocaine and the HIV protein, Tat. Results from these studies point to a new pathway in the CNS that may contribute to HAND in HIV+ cocaine users. / Biomedical Sciences
|
Page generated in 0.0468 seconds